Clinical Trial Update: Percutaneous Treatment of Tricuspid Valve Regurgitation With the TriCinch System™ [Phase 1]

View source ↗

Summary

Phase 1 trial assessing the TriCinch System for percutaneous treatment of tricuspid regurgitation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tricuspid Regurgitation

Drugs mentioned

• TriCinch System

Snippet

Sponsor: 4Tech Cardio Ltd. | Conditions: Tricuspid Regurgitation | Phase 1 | Status: COMPLETED